Below is my take on the half year result. I'll have used the P&L format from BAL's annual report. Obviously there are assumptions (explanation at bottom) but here goes:
Infant sales based on A2 guidance of 68 million sales to end of December. I assume BAL, as market leader, stock out would be double A2 sales (conservative). Non-infant - took 15% from 2015 sales (19.75m) and growth was 170% from previous year. I assume 90% growth divided by 2. With cost of sales i took the trend line from 2014-2015 figures. Again was conservative. Two important factors are sales and cost of sales - will determine the bottom line. For example a 10% increase in sales would increase NPAT by 2 million.
Column 1 Column 2 Column 3 0 Sales – Infant 136million 1 Non-Infant 19.3 2 Gross Sales 155.3 3 Less trading rebates (2.42%) 3.7 4 Revenue 151.6 5 Cost of Sales (67.41%) 102.10 6 Gross Profit 49.50 7 Less Distribution/Selling (5.25%) 7.9 8 Employee Costs (2.5%) 3.8 9 Marketing & Promotion (1.25%) 1.9 10 Administrative & Other (2.4%) 3.6 17.2 11 EBIT 32.3 12 Less interest 0.4 13 Profit before tax 31.9 14 Tax (30.1%) 9.6 15 NPAT (half year) 22.3
So with the price increase and increase supply to kick in for 2nd half then annualised 2016 NPAT could be over 50million. Please DYOR.
- Forums
- ASX - By Stock
- BAL
- Potential 1st half result.....
Potential 1st half result.....
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online